Becton Dickinson Euro Finance S.a. r.l., founded in 2007 and headquartered in Luxembourg, is a financing subsidiary of Becton, Dickinson and Company, aimed at managing the funding needs of its parent company within the European market. The company primarily focuses on issuing bonds to garner capital, supporting Becton Dickinson's diverse medical technology and diagnostic product lines.
| Bond Name | Country | Maturity | Coupon(%) | |
|---|---|---|---|---|
| BDX 0.33% 2028-08-13 EURBecton Dickinson Euro Finance S.a. r.l. | Luxembourg | 2028-08-13 | 0.334 | 2.53 |
| BDX 1.21% 2026-06-04 EURBecton Dickinson Euro Finance S.a. r.l. | Luxembourg | 2026-06-04 | 1.208 | 2.28 |
| BDX 1.21% 2036-02-12 EURBecton Dickinson Euro Finance S.a. r.l. | Luxembourg | 2036-02-12 | 1.213 | 3.83 |
| BDX 1.34% 2041-08-13 EURBecton Dickinson Euro Finance S.a. r.l. | Luxembourg | 2041-08-13 | 1.336 | 4.20 |
| BDX 3.55% 2029-09-13 EURBecton Dickinson Euro Finance S.a. r.l. | Luxembourg | 2029-09-13 | 3.553 | 2.84 |
Company overview and issue history are AI generated, and should not be cited or relied on without verification.
Since its inception, Becton Dickinson Euro Finance has actively engaged in the bond market, issuing its first bond in 2010 as a strategic move to enhance liquidity and fund corporate growth. Significant issuances include a €500 million bond in 2014, which was notable for its 10-year maturity and competitive yield compared to industry norms. As of 2023, current yields on their bonds remain attractive relative to peers, reflecting strong creditworthiness, while features like callable bond options enhance their appeal among investors.